Silo PharmaSILO
13F holders, Q3 2025 (September 30)14holders +1
6new positions
5sold out
$0.69avg. 13F price*
At the end of Q3 2025, 14 institutions reported holding Silo Pharma Inc. (SILO) in their 13F filings, up 1 from Q2 2025. 6 opened new positions and 5 sold out. The largest holders were Anson Funds Management LP ($657K), AdvisorShares Investments LLC ($252K) and Virtu Financial LLC ($74K).
- Company
- Silo Pharma Inc.
- CUSIP
- 82711P201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $758K |
| Exits | 5 | $69K |
All 13F filers, Q2 2025 → Q3 2025: 1,280,331 shares bought and 136,123 shares sold, net +1,144,208 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Anson Funds Management LP | 0.08% | New | 952,381 | $657K |
| AdvisorShares Investments LLC | 0.04% | Add +98.0% | 364,878 | $252K |
| Virtu Financial LLC | 0.00% | New | 107,786 | $74K |
| Geode Capital Management, LLC | 0.00% | Add +0.7% | 39,596 | $27K |
| Jane Street Group, LLC | 0.00% | New | 16,772 | $12K |
| Two Sigma Securities, LLC | 0.00% | Reduce -61.9% | 16,471 | $11K |
| Vanguard Group Inc. | 0.00% | No change | 16,334 | $11K |
| StoneX Group Inc. | 0.00% | New | 13,430 | $9K |
| State Street Corp. | 0.00% | No change | 12,500 | $9K |
| UBS Group AG | 0.00% | New | 8,984 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -1.5% | 1,707 | $1K |
| Westside Investment Management, Inc. | 0.00% | No change | 94 | $65 |
| Bank of America Corp. | 0.00% | Add +88.1% | 79 | $55 |
| Wells Fargo & Company | 0.00% | New | 10 | $7 |
"% of holder's portfolio" is SILO's weight in each manager's 13F, not the share of Silo Pharma Inc. the manager owns.